Home
RNAC
RNAC News

Latest Cartesian Therapeutics Inc. (RNAC) News on January 19, 2025

Argus Research

3 days ago

Daily – Vickers Top Buyers & Sellers for 01/16/2025

Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases

GlobeNewswire

6 days ago

Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

12 days ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Argus Research

23 days ago

Daily – Vickers Top Buyers & Sellers for 12/27/2024

Argus Research

24 days ago

Daily – Vickers Top Buyers & Sellers for 12/26/2024

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 12/24/2024

Cartesian Therapeutics initiated with a Buy at BTIG

TipRanks

a month ago

Cartesian Therapeutics initiated with a Buy at BTIG

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

a month ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Reports Promising Phase 2b Trial Results

TipRanks

a month ago

Cartesian Therapeutics Reports Promising Phase 2b Trial Results

Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial

GlobeNewswire

2 months ago

Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial

Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit

GlobeNewswire

2 months ago

Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit

Timothy Springer Bought 4.9% More Shares In Cartesian Therapeutics

Simply Wall St.

2 months ago

Timothy Springer Bought 4.9% More Shares In Cartesian Therapeutics

Yale University's Strategic Bet on Cartesian Therapeutics Skyrockets in Q3 2024

GuruFocus.com

2 months ago

Yale University's Strategic Bet on Cartesian Therapeutics Skyrockets in Q3 2024

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

2 months ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

2 months ago

Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting

GlobeNewswire

2 months ago

Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting

Bullish Cartesian Therapeutics Insiders Loaded Up On US$5.18m Of Stock

Simply Wall St.

3 months ago

Bullish Cartesian Therapeutics Insiders Loaded Up On US$5.18m Of Stock

Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting

GlobeNewswire

3 months ago

Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 10/07/2024

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

3 months ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis

GlobeNewswire

4 months ago

Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis

Cartesian Therapeutics Announces New Employment Inducement Grant

GlobeNewswire

4 months ago

Cartesian Therapeutics Announces New Employment Inducement Grant

Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15

GlobeNewswire

5 months ago

Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

5 months ago

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

5 months ago

Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

5 months ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

6 months ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik

GlobeNewswire

7 months ago

Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik

Cartesian Therapeutics Plummets On 'Watershed Moment' For CAR-T Drugs

Investor's Business Daily

7 months ago

Cartesian Therapeutics Plummets On 'Watershed Moment' For CAR-T Drugs

Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus

GlobeNewswire

7 months ago

Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

GlobeNewswire

7 months ago

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis

GlobeNewswire

7 months ago

Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

7 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

7 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

7 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

7 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

7 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

7 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

7 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

7 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Cartesian Therapeutics Announces New Employment Inducement Grant

GlobeNewswire

7 months ago

Cartesian Therapeutics Announces New Employment Inducement Grant

Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis

GlobeNewswire

8 months ago

Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis

Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

GlobeNewswire

8 months ago

Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

GuruFocus.com

8 months ago

Cartesian Therapeutics Inc (RNAC) Reports Q1 2024 Earnings: A Detailed Financial and ...

Cartesian Therapeutics Reports First Quarter 2024 Earnings

Simply Wall St.

8 months ago

Cartesian Therapeutics Reports First Quarter 2024 Earnings

Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Cartesian Therapeutics Announces New Employment Inducement Grants

Business Wire

8 months ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting

Business Wire

9 months ago

Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting

Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Business Wire

9 months ago

Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Cartesian Therapeutics Announces New Employment Inducement Grants

Business Wire

9 months ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split

GlobeNewswire

10 months ago

Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split

Cartesian Therapeutics Director Acquires 3.2% More Stock

Simply Wall St.

10 months ago

Cartesian Therapeutics Director Acquires 3.2% More Stock

Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

10 months ago

Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

10 months ago

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

Cartesian Therapeutics Announces New Employment Inducement Grant

GlobeNewswire

10 months ago

Cartesian Therapeutics Announces New Employment Inducement Grant

Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland

GlobeNewswire

10 months ago

Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland

Cartesian Therapeutics, Inc.'s (NASDAQ:RNAC) market cap rose US$14m last week; retail investors who hold 50% profited and so did insiders

Simply Wall St.

a year ago

Cartesian Therapeutics, Inc.'s (NASDAQ:RNAC) market cap rose US$14m last week; retail investors who hold 50% profited and so did insiders

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

a year ago

Cartesian Therapeutics Announces New Employment Inducement Grants

If You Invested $5,000 in Aurora Cannabis in 2019, This Is How Much You Would Have Today

Motley Fool

a year ago

If You Invested $5,000 in Aurora Cannabis in 2019, This Is How Much You Would Have Today

Viemed Healthcare, Inc.'s (NASDAQ:VMD) institutional shareholders had a great week as one-year returns increased after a 12% gain last week

Simply Wall St.

a year ago

Viemed Healthcare, Inc.'s (NASDAQ:VMD) institutional shareholders had a great week as one-year returns increased after a 12% gain last week

Associated Press Finance

a year ago

Eagle Bancorp: Q4 Earnings Snapshot

Eagle Bancorp, Inc. Announces Net Income For Fourth Quarter 2023 Of $20.2 Million Or $0.67 Per Diluted Share

GlobeNewswire

a year ago

Eagle Bancorp, Inc. Announces Net Income For Fourth Quarter 2023 Of $20.2 Million Or $0.67 Per Diluted Share

NAVIGATING TOMORROW: Japan Airlines Cargo Chooses WebCargo for Global Digital Expansion

PR Newswire

a year ago

NAVIGATING TOMORROW: Japan Airlines Cargo Chooses WebCargo for Global Digital Expansion

Zevra Therapeutics Appoints Experienced Biopharma Executive Alvin Shih, MD, MBA, to the Board of Directors

GlobeNewswire

a year ago

Zevra Therapeutics Appoints Experienced Biopharma Executive Alvin Shih, MD, MBA, to the Board of Directors

Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")

ACCESSWIRE

a year ago

Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")

Natural Grocers® Provides Free Filtered Water to Communities Affected by Boil Water Advisory in Topeka, KS

PR Newswire

a year ago

Natural Grocers® Provides Free Filtered Water to Communities Affected by Boil Water Advisory in Topeka, KS

The Market’s Gains Won’t Come Easy From Here, Barron’s Roundtable Pros Say. 8 Stocks for Now.

Barrons.com

a year ago

The Market’s Gains Won’t Come Easy From Here, Barron’s Roundtable Pros Say. 8 Stocks for Now.

Data Analytics Stocks Q3 Recap: Benchmarking Domo (NASDAQ:DOMO)

StockStory

a year ago

Data Analytics Stocks Q3 Recap: Benchmarking Domo (NASDAQ:DOMO)

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity

GlobeNewswire

a year ago

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity

Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis

GlobeNewswire

a year ago

Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Zoomcar, the World’s Largest Emerging Market Focused Car Sharing Platform, Announces Completion of its Business Combination with Innovative International Acquisition Corporation (IOAC) and Anticipated Nasdaq Listing

HIVE Digital Announces Closing of $28.75 Million Bought Deal Private Placement Financing to “HODL” Our Bitcoin Production and Expand Green Mining Footprint

GlobeNewswire

a year ago

HIVE Digital Announces Closing of $28.75 Million Bought Deal Private Placement Financing to “HODL” Our Bitcoin Production and Expand Green Mining Footprint

NN's (NASDAQ:NNBR) growing losses don't faze investors as the stock surges 23% this past week

Simply Wall St.

a year ago

NN's (NASDAQ:NNBR) growing losses don't faze investors as the stock surges 23% this past week

Retail investors account for 42% of CNFinance Holdings Limited's (NYSE:CNF) ownership, while institutions account for 29%

Simply Wall St.

a year ago

Retail investors account for 42% of CNFinance Holdings Limited's (NYSE:CNF) ownership, while institutions account for 29%

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right

PR Newswire

a year ago

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right

Will Gambling.com (GAMB) be a Strong Long-Term Compounder?

Insider Monkey

a year ago

Will Gambling.com (GAMB) be a Strong Long-Term Compounder?

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Simply Wall St.

a year ago

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

SmartFinancial Announces Transfer Of Listing Of Common Stock To The New York Stock Exchange

GlobeNewswire

a year ago

SmartFinancial Announces Transfer Of Listing Of Common Stock To The New York Stock Exchange

Insider Buying: Taysha Gene Therapies Board Observer Bought US$163k Of Shares

Simply Wall St.

a year ago

Insider Buying: Taysha Gene Therapies Board Observer Bought US$163k Of Shares

Investors in Luxfer Holdings (NYSE:LXFR) have unfortunately lost 59% over the last five years

Simply Wall St.

a year ago

Investors in Luxfer Holdings (NYSE:LXFR) have unfortunately lost 59% over the last five years

Trinseo Announces Quarterly Dividend of $0.01 Per Share

Business Wire

a year ago

Trinseo Announces Quarterly Dividend of $0.01 Per Share

L’Officiel HK successfully registered all magazines with the HK SAR Government’s Office for Film, Newspaper and Article Administration

Business Wire

a year ago

L’Officiel HK successfully registered all magazines with the HK SAR Government’s Office for Film, Newspaper and Article Administration

Point, Redwood Trust issue $139M home equity investment securitization

HousingWire

a year ago

Point, Redwood Trust issue $139M home equity investment securitization

Business Wire

a year ago

EVI Industries Reports Record First Quarter Results

What Makes Seneca Foods Corp. (SENEA) an Attractive Opportunity?

Insider Monkey

a year ago

What Makes Seneca Foods Corp. (SENEA) an Attractive Opportunity?

Share on Social Networks: